CAS 1796568-94-9

AC-SDKP TRIFLUOROACETATE

CAS: 1796568-94-9

AC-SDKP TRIFLUOROACETATE is a synthetic peptide, which is a derivative of the naturally occurring tetrapeptide L-seryl-L-aspartyl-L-lysyl-L-proline. This product is typically sourced through chemical synthesis, enabling precise structural and functional consistency.The mode of action of AC-SDKP involves its role as an endogenous antifibrotic agent. It functions by inhibiting the proliferation and differentiation of fibroblasts, thereby reducing collagen deposition. This action largely contributes to its ability to prevent fibrosis in various tissues. Additionally, AC-SDKP is known for its cardiovascular protective effects, partially through its interaction with the renin-angiotensin system and its ability to reduce inflammation.AC-SDKP TRIFLUOROACETATE is primarily used in scientific research focused on fibrotic diseases and cardiovascular disorders. It is a valuable tool for studying pathological mechanisms underlying fibrosis and developing potential therapeutic strategies. Its applications extend to investigating myocardial fibrosis, renal fibrosis, and idiopathic pulmonary fibrosis, among others, providing insights into treatment approaches that aim to mitigate disease progression.

Formula: C₂₀H₃₃N₅O₉•C₂HF₃O₂

Molecular weight: 601.53 g/mol

Ref: 3D-PA16917